chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red hands; Back of the hands red and tender; Swollen wrists; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red hands), TENDERNESS (Back of the hands red and tender) and JOINT SWELLING (Swollen wrists) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) and VITAMINS NOS for an unknown indication.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (Red hands), TENDERNESS (Back of the hands red and tender) and JOINT SWELLING (Swollen wrists). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red hands), TENDERNESS (Back of the hands red and tender) and JOINT SWELLING (Swollen wrists) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment taken for the events included Cortisone cream however the patient reported administration did not help to relieve his symptoms.
On 02/24/2023 I started to experience sinus pain. I went to urgent care for what I thought was a Sinus infection and tested positive for COVID-19. No prescriptions were provided.
After leaving  about 5 minuets my mouth got a metal taste it in.  I have a dental bridge and the left tooth where is it attached only this tooth had the metal taste.  I waited the next day and after a few      hours it stopped.  But then I got a metal taste on the front of my tongue this also stopped the next day.  I did not report these reactions to my dentist or doctor since they stopped after one day
6/17/22: within 30 minutes, experienced bilateral numbness in legs/arms, shortness of breath and fatigue; 6/18/22: fatigue, numbness in legs/arms, intermittent swelling and pain in face, rash on arms, chest and back for 2-3 days; on 6/21/22: cough, headache and legs purplish color; all symptoms resolved in 1 week
7.5 cm x 9 cm area of redness with warmth, raised on right deltoid. 3-6-17 - follow up call placed - spoke with grandparent, states swelling has gone down.
2 days after vaccination (13-13-09) noticed soreness in muscle of arm. Pain still comes and goes. Tx with ADVIL with heat.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 12Nov2021 as dose 2, single (Batch/Lot number: unknown) at the age of 63 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 15Jun2021 as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing), notes: COPD; "HTN" (unspecified if ongoing), notes: HYN; "DB" (unspecified if ongoing), notes: DB. The patient's concomitant medications were not reported. Past drug history included: Pcm, reaction(s): "Known allergies: PCM". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Took prescribed dose of Paxlovid one week later started coughing wheezing horrible runny nose. Tested positive for COVID. Therapeutic measures were taken as a result of covid-19.  Additional information: Serious: No. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: No. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No. Other medication in 2weeks Yes. Anti viral details: product=COVID 19 Treatment, brand=Paxlovid, treatment start date=25Jul2022, treatment stop date=30Jul2022. other medication details: other medication in 2weeks brand=Metoprolol. other medication in 2weeks brand=Losartan. other medication in 2weeks brand=Atorvastatin. other medication in 2weeks brand=Metformin. Adverse event: Took prescribed dose of Paxlovid one week later started coughing wheezing horrible runny nose. Tested positive for COVID. Adverse event start date: 05Aug2022. AE resulted in: [None of the above]. The patient was recovering. Treatment Ae: Yes. Ae treatment : Steroids Mucinex. Other medical history: COPD, HYN, DB. Device timestamp: 11Aug2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received dose 1 Moderna Vaccine in February 2021  and dose 2 Moderna in March 2021.  Received Pfizer booster dose today, October 21, 2021.
Vaccine date 4/7/21.  Facial droop & Right arm weakness 4/11/21.  Admitted to hospital observation to evaluate for stroke.  Neuro consult determined it to be Bells Palsy.  Pt discharged to home 4/12/21 on Predisone with some improvement in symptoms.
On 11/29/2021 @ 14: 30 Pt received a Pfizer booster vaccine 0.25 ml. vaccine was expired by 50 minutes. supervisor notified .
pt recv vax & devel an inj site rxn;No further details known as of the date of this report;This is one of three patients from this site who exp above rxn;
Extreme Fatigue continues to increase, Elevated Liver functions, Enlarged Liver and Heart Tachycardia.
I?ve had pain in both legs off and on since the Janssen shot.  Had an issue with clots and blood supply in previous and recent pregnancies
About 5:00pm itchy scratchy throat, tightness, red scratchy eyes, mucus collected in corner of eyes. Shivers (did not have thermometer), nausea could not eat dinner. Took Benadryl about 5:30, Tylenol 6:00, felt better about 8:00-8:30 pm.
ARRHYTHMIA; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer Pfizer concerned a 74 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: hyperparathyroid, glaucoma, hypothyroid, lyme disease, osteoarthritis, and drug allergy (Timolol maleate, GTTs (drops), Levofloxacin allergy). The patient was health care professional. The patient was not pregnant at the time of vaccination. The patient previously received two doses of  Moderna COVID-19 vaccine (elasomeran) (Dose number in series 1) first dose (form of administration and route of administration were not reported , batch number: 013L20A, and expiry: unknown) dose was not reported, administered on left arm on 19-JAN-2021 at 18:00 for covid-19 prophylaxis and received second dose (form of administration and route of administration were not reported , batch number: 031L20A, and expiry: unknown) dose was not reported, administered on left arm on 16-FEB-2021 at 18:00 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following 2 doses of vaccination with Moderna COVID-19 vaccine (elasomeran) (Dose number in series 1). The patient received Pfizer (tozinameran) (Dose number in series 2) (form of admin and route of admin were not reported, batch number: FH8020, expiry: unknown) dose was not reported, administered on left arm on 23-OCT-2021 at 13:15 for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with Pfizer (tozinameran) (Dose number in series 2). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 3) (suspension for injection, route of admin not reported, batch number: 1855190 expiry: UNKNOWN) dose was not reported, 1 total administered on left arm on 07-MAY-2022 14:30 for covid-19 prophylaxis. Age at time of vaccination 54 years old. No concomitant medications were reported. On an unspecified date in 2022, the patient experienced covid-19 infection (suspected covid-19 infection) and received non company suspect paxlovid (form of administration, oral, batch number: PAA188252, expiry: unknown) dose was not reported, administered from 05-JUL-2022 to 07-jul-2022 for covid-19 treatment. On 05-JUL-2022 18:00, the patient experienced arrhythmia (Dose number in series 3). The action taken with covid-19 vaccine ad26.cov2.s and paxlovid was not applicable. The patient recovered from arrhythmia on 06-JUL-2022, and the outcome of suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220737469-covid-19 vaccine ad26.cov2.s-arrhythmia. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY [ hyperparathyroid, hypothyroid]. Therefore, this event(s) is considered not related.
pt recv vax on 7AUG96 & devel chicken pox (2 vesicles & flu-like sx) on 3SEP96;
Patient is a 39 year old in the observation area post COVID 19 vaccine, presents with bounding/fast heart rate 10 mins post vaccination. No CP, SOB, angioedema. Pt endorsed that he is a little nervous about the vaccine because of adverse effects. Vital signs normal. Physical exam unremarkable. Given water for hydration. Palpitations improved. ED precautions given. Sent home stable.
This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 12-NOV-2021, while administering vaccine hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1780867, expiration date 08-AUG-2023 for prophylaxis (exact dose, anatomical location and route of administration were not reported), the finger flange broke (Syringe broken) and cut the health care professional (HCP) (Laceration of finger). The patient receiving the vaccine had no injury and received all of the vaccine. The office manager reported that they still have the defective product and no damage had been noted to the cartoon or that specific syringe before use. There was no difficulty trying to attach the syringe needle to the syringe and the syringe broke during use into 2 or more pieces. The syringe tip cap was attached properly prior to use and the syringe tray was intact and undamaged on receipt. The outcome of the event was unknown. The reporter considered the event of laceration of finger to be related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). This is one of two reports received from the same reporter. Sender's Comments:  US-009507513-2111USA009249:
The decedent died a few days after receiving the booster for COVID-19 and flu shot. She complained of not feeling well (unknown symptoms) since she received the two vaccines.
pt recvd vax; devel lymphadenopathy;mom had similar rxn before;
The patient was to receive Pfizer, but was administered Moderna instead. The patient has not had any issues, but per company policy we report vaccines errors to VAERS. As of today 8/18 (the vaccine was given 8/17) the patient has not reported any adverse events.
patient did not have any adverse effects or symptoms; Caller is a nurse who reports that she has a box of ROTATEQ in which the foil pouches containing ROTATEQ are unsealed. Three doses have been given out of that box; the caller does not know whether the foil pouches containing the administered doses we; Caller is a nurse who reports that she has a box of ROTATEQ in which the foil pouches containing ROTATEQ are unsealed. Three doses have been given out of that box; the caller does not know whether the foil pouches containing the administered doses we; the caller does not know whether the foil pouches containing the administered doses were also unsealed; This spontaneous report was received from a registered nurse referring to a 7 weeks old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.    On 06-APR-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (lot # 1742077, expiration date 12-SEP-2022, 2 milliliter, oral) for prophylaxis. A box of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) in which the foil pouches containing rotavirus vaccine, live, oral, pentavalent(ROTATEQ) were unsealed, the dose had been given out of that box, the reporter did not know whether the foil pouches containing the administered dose was also unsealed (poor quality product administered, product container seal issue and circumstance or information capable of leading to medication error). The open pouches were not noticed until 11-MAY-2022. The patient did not have any adverse effects or symptoms following administration of the vaccine.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2205USA003333: US-009507513-2205USA003247:
Got vaccine, had severe case of shingles/Suspected vaccination failure; severe shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 7-Oct-2022 Reporter's comment: The case was received from the patient's friend via interactive digital media. The patient's friend reported that the patient never had shingles but after getting the shingles vaccination, had sever case of the shingles. The case was linked with case US2022AMR144803 reported by same reporter for different patient. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR132558:Same reporter US-GSK-US2022AMR144803:Same reporter
Continued soreness at injection site .. to this day its sore in a quarter sized area No taste or smell .. except a metallic taste and smell Lost taste and smell with first vaccine but gained back after a few days but after second vaccine I have not regained smell or taste except the metallic taste and sometimes a metallic smell
Loss of balance, loss of use of lower body, weakness in arms, no reflexes in lower body, inability to walk, stand or sit unassisted.
Nurse was at facility that said they had done all system look ups prior to the clinic and patients attending were due for their boosters.  Patient was vaccinated without incident. When patient was being entered into system after the vaccination, it was noted that he had received 2nd shot in primary series on  11/30/21 and was not yet eligible for a booster.  Nursing director.  Process has been changed that all patients are being checked in system prior to being vaccinated.
A case of persistent itching and swelling(hives?) that persists 2-3 days after vaccinations taken Based on my research this may be hives and could persist for less than 6 weeks... I will take this to a doctor if it persists for more than 2 weeks..
This initial spontaneous report was received from a nurse, refers to a 6 year old female patient. Concurrent conditions and medical history were not provided. The nurse stated that on 23-JAN-2009, the patient was vaccinated with the first dose of hepatitis b vaccine (manufacturer unknown) (dose, route, lot # and expiration date not provided) on 26-JUN-2009. There was no concomitant medication described. No adverse effects reported. Additional information has been requested.
patient was noted to be flushed by residential home staff on 12/30/2020, approximately 2.5hrs after vaccination, fever present at that time. Prior to COVID19 vaccine administration, this patient did have exposure and was close contact with a known case of COVID19 in a residential care employee. Patient was taken to hospital for evaluation of febrile status, had positive COVID19 test at that time, and reported hypotension per residential care staff.
Event occurred after 2nd vaccine.  Patient is an 86-year-old female presents to ED on 12/24/21 secondary to falls   and generalized weakness.  Patient's son is Covid positive.  Patient denies shortness of breath pain in the abdomen or chest, denies nausea vomiting or diarrhea. Denies Symptoms: no abdominal pain/ no chest pain/ no chills/ no cough/ no discharge/ no fever/ no headache/ no nausea/ no palpitations/ no rash/ no shortness of breath/ no URI symptoms/ no vomiting.   In the ED patient was tachycardic and tachypneic. Patient was placed on 2L NC. CXR showed Tiny left pleural effusion versus scarring in this region. Lactic acid was elevated. Problem 1: Acute respiratory failure Plan 1: - Likely secondary to COVID-19 - on no home O2, currently on 3L NC  - Titrate oxygen to keep saturation >90% - Remdesevir X5 days or until hospital discharge  - Dexamethasone 6 mg daily x9 days - Monitor chest x-ray and inflammatory markers - D Dimer elevated - DVT prophylaxis with Lovenox 40mg CXR:12/27/2021:  Bibasilar opacities have slightly increased, may represent atelectasis and/or airspace disease
CONTINUOUSLY WORSENING PAIN ON ENTIRE LEFT SIDE OF BODY; MILD SWELLING; SOME SENSE OF NUMBNESS; MUSCLE ACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 13-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced continuously worsening pain on entire left side of body, mild swelling, some sense of numbness, and muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the continuously worsening pain on entire left side of body, muscle ache, mild swelling and some sense of numbness was not reported. This report was non-serious.
IN 24HOURS my husband had a seizure and I found him unresponsive and was taken to the hospital in an ambulance,  2 weeks in hospital with organs failing etc  and his kidneys are still coming back.   He appears to hopefully be a full recovery.  Doctors say they do not know enough about the vaccine to say it was the cause although he had blood work taken 3 days prior. and all good.  He had a lot of tests due to finding that he had 2 very old strokes.
Heart pains; A rash started; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 14-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0187), dose 2 via an unspecified route of administration, administered in Arm Left on 17Jun2021 15:30 (at age of 14 -year-old) as DOSE 2, SINGLE for covid-19 immunisation. No other medical history. No known allergies. No COVID prior vaccination. The patient did not take concomitant medications (No other medications in two weeks). No other vaccine in four weeks. Patient previously had first dose of BNT162B2 (lot number: EW0178) on 27May2021 at 03:30 PM (at age of 14 -year-old) for COVID-19 immunisation. On 21Jun2021 08:30, the patient experienced heart pains and a rash started. Adverse event treatment was Ibuprophen, Benadryl. Outcome of event was recovering.   Follow up attempts are completed. No further information is expected.
I started having ringing in my left ear (tinnitus) after my first dose. Its been almost a week and the ringing is still present
SMALLPOX VACCINE ASSOCIATED CELLULITIS 9 DAYS POST ADMINISTRATION DATE
I felt like flared up and had a horrible headache like I was on a boat and I kept falling over. Body inflamed and joints hurt everywhere like a nerve thing. Its the same reaction as the Metronidasole ( Flagyl). Saw doctor 5oct2021. I had to get help to look after my kids and I couldn't drive because I was still dizzy. He didn't think it was the vaccine and no other test done other than covid.
Sever Headache started  on Sunday 10/31 following the vaccination and continued for multiple days. I did not think to check my Blood pressure until a doctor checked it on 11/2 and it was 170s/110s. It onto us to rise on 11/2/21  and I went to emergency room for treatment on 11/2 evening and 11/3 evening.  This is now onset acute hypertension. Medication was needed to control and maintain the blood pressure . By three months following the booster I am no longer in medication.
Pt reported nausea at 10:34am. Vitals were evaluated. b/p 102/78 p 111 o2 99%. Pt reassessed at 10:37am. cont to  c/o nausea. pulse 105 o2 99%.  Pt reassessed at 10:40. Deneid nausea. Pulse 108, o2 99.  Pt released by MD.
Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for heart murmur, COPD, sleep apnea, DM, hyperlipidemia, HTN. Lack of information regarding death. Patient deceased 3/31/2021 at age 85 per wife.
After administrative of 3 vaccines patient was observed to turn pale and referred feeling a little bit dizzy. He was placed and the stretcher vitals assessed and left under observation. After 10 to 15 mins. he was sit. it and symptoms were resolve. Vitals remained stable all the time.
Around 430AM woke up asking for a drink of water. When he didn't drink the water mom saw he was having an active seizure. Had white pasty stuff around his mouth. Uncle call 911. No idea how long it lasted. When ambulance staff transported child to ER they placed ice packs around him. Child was given purple liquid in ER parent not sure what it was. Given TYLENOL for at home.
The pt was brought in by mother on 2/21/00. The pt had no previous reactions, allergies or illnesses. Approximately 5 minutes post vax the pt experienced small red raised bumps on forehead, behind both ears, above and below eyes, jaw bone area and upper chest area. No breathing problems noted. The mother was instructed to seek immediate attention via private physician or ER.
FEVER 101.0, WEAKNESS, JOINT PAIN, NAUSEA, CHILLS.
no adverse event; Incorrect product storage; This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.  On 10-MAR-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) dose/ frequency: 1,  lot # T015598, expiration date 02-NOV-2021, for prophylaxis (route were not reported).  The temperature involved was 16.5 degrees F for 4 hours. The previous temperature excursion was 14.5 degrees F for 2 hours and 45 minutes, 15.6 degrees F for 3 hours and 21 degrees F for 5 hours and 30 minutes. A data logger was involved.   This is one of multiples cases received from the same reporter.